Related Experiment Videos
Characterization of vitiligo antigens
1Ronald O. Perelman Department of Dermatology, New York University, USA.
Pigment Cell Research
|February 1, 1995
Summary
Patients with vitiligo possess antibodies targeting specific pigment cell antigens (VIT 90, VIT 75, VIT 40). These antigens are distinct from those identified by most available monoclonal antibodies, suggesting novel targets for vitiligo research.
Area of Science:
- Immunodermatology
- Autoimmunity
- Melanocyte Biology
Background:
- Vitiligo patients exhibit circulating antibodies against pigment cell antigens.
- Key antigens, designated VIT 90, VIT 75, and VIT 40, have molecular weights of approximately 90, 75, and 40-45 kD, respectively.
- The precise nature and relationship of these vitiligo antigens to known pigment cell markers remain to be fully elucidated.
Purpose of the Study:
- To characterize vitiligo-associated antigens (VIT 90, VIT 75, VIT 40).
- To investigate the relationship between these antigens and those defined by a panel of monoclonal antibodies (mAbs) against pigment cell antigens.
- To determine if VIT antigens represent novel targets in vitiligo autoimmunity.
Main Methods:
- Immunoprecipitation and SDS-PAGE analysis of radiolabeled human melanocyte macromolecules.
- Comparison of antigen reactivity using a panel of 25 monoclonal antibodies.
- Immunodepletion studies to assess antigen specificity.
- Cell surface labeling techniques (lactoperoxidase and 35S-methionine) to evaluate antigen localization.
Main Results:
- A high prevalence (83%) of antibodies to VIT antigens was observed in vitiligo patients compared to controls (7%).
- Only four of 25 mAbs precipitated antigens that co-migrated with VIT antigens.
- Monoclonal antibodies targeting tyrosinase-related protein 1 (TRP1) co-migrated with VIT 75, but immunodepletion confirmed VIT 75 is not TRP1.
- Monoclonal antibody W6/32 (anti-class I HLA) co-migrated with VIT 40, suggesting a shared epitope or tight binding.
- VIT antigens showed preferential cell surface expression.
Conclusions:
- VIT 90 and VIT 75 are distinct from known pigment cell antigens recognized by current mAbs.
- VIT 40 may share an epitope with or be associated with class I HLA antigens.
- These findings identify potentially novel autoantigens in vitiligo, offering new avenues for understanding disease pathogenesis and developing targeted therapies.